Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors

INCLUSION CRITERIA BOTH GROUPS * M/F * Patient agrees to follow study protocol and is able to follow study procedures * Patient signed, dated and understood consent form * Patient has a social security scheme CASE GROUP * Patient is 18 or older * Patient for whom a bladder cancer recently diagnosed, or backsliding/progression is heavily suspected after the initial fibroscopy * Patient who hasn't started systemic/oral/radiotheurapeutic pelvic treatment for his/her tumor CONTROL GROUP * Patient between 18 and 45 y/o * Patient not suspected of having any bladder cancer * Patient attending or hospitalized for urolithiasis, urinary infections, superior excretory stones or with non suspect urinary symptomatology * Patient who hasn't been exposed to bladder carcinogens (tobacco, industrial carcinogen (ex: coal tar, tar/coal oils, coal pitch and burning coal soot), urinary bilharzia, chemotherapy exposition (cyclophosphamid) * Patient that had a negative cytopathological exploration of the excretory urinary route OR/AND iconography (pelvic echography, pelvic scanner) OR/AND endoscopy with prior urinary sample * Patient unscathed of any cancer that might interact with bladder cancer : uterine cancer, prostate cancer, rectal cancer, and metastasis from other cancer or non-urologic tumor invading the bladder EXCLUSION CRITERIA BOTH GROUPS * Non-treated current urinary infection * Patient with another pelvic cancer * Bladder cancer outside of urothelial carcinoma * Associated carcinoma of the high urinary apparatus * Patient that received renal transplantation (BK virus) * Patient that received pelvis radiotherapy (related to prostatic cancer, gynecologic cancer or pelvic digestive cancer) * Patient having a JJ catheter * Refused to signed consent * Pregnant, susceptible to be, or breast-feeding women * Person Under guardianship * Impossibility to submit to medical monitoring because of geographic, social, or mental issues CASE GROUP • Under 18y/o CONTROL GROUP • Under 18y/o or above 45 y/o